Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Study Shows Broader Benefit for Life-Saving Procedure After Stroke
Clinical Breakthroughs

Study Shows Broader Benefit for Life-Saving Procedure After Stroke

By Anna WilliamsFeb 9, 2018
Share
Facebook Twitter Email
ansari-md-sameer-a-2010-lbp2110
Sameer A. Ansari, MD, PhD, associate professor of Radiology, Neurology, and Neurological Surgery, was a co-author of the study published in The New England Journal of Medicine.

An emergency procedure to remove large blood clots may be beneficial in far more stroke patients than previously thought, potentially saving many more lives, according to findings from a new multicenter trial published in The New England Journal of Medicine.

Sameer A. Ansari, MD, PhD, associate professor of Radiology, Neurology, and Neurological Surgery was a co-author of the study.

Ischemic strokes, which account for about 85 percent of the 750,000 strokes suffered each year in the U.S., occur when a clot cuts off blood flow to the brain, resulting in damage to brain cells.

An emergency procedure called a thrombectomy, which surgically removes the clot from a blood vessel to restore circulation, can improve patient outcomes in some cases. But in the past, thrombectomy was only recommended when performed within six hours after the onset of symptoms. As a result, under the previous guidelines, many patients missed out on treatment, especially since strokes can often occur during sleep.

In the current study, called DEFUSE 3, the investigators wanted to assess whether patients suffering an acute ischemic stroke — the most severe and debilitating type of ischemic stroke — would benefit from a thrombectomy if performed between six and 16 hours after symptoms, when compared to standard medical therapy alone. The trial was designed to include only patients who were first identified as having salvageable brain tissue through special brain imaging software, who would be the most likely to benefit from the restoration of blood flow.

The trial, which randomized 182 patients at 38 centers across the U.S., found that in this select group of patients, thrombectomy resulted in improved outcomes: 45 percent of patients in the intervention group were considered functionally independent 90 days after treatment, compared to just 17 percent who did not have the procedure. Furthermore, the mortality rate was 14 percent in the thrombectomy group, and 26 percent in the control; both findings are statistically significant.

“This landmark clinical trial showed that with careful patient and CT/MR imaging selection to identify brain tissue that was still salvageable beyond the traditional six-hour interventional window, up to 16 hours, mechanical thrombectomy was safe and effective in improving patients’ clinical outcomes,” Ansari said.

The study’s findings, together with a previous trial that had similar results, led the American Heart Association and the American Stroke Association to release updated guidelines expanding the time frame for the procedure.

The DEFUSE 3 trial was funded by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH).

Ansari is currently also the principal investigator of an NIH-funded study assessing the use of high-resolution and functional MRI techniques to identify patients with intracranial atherosclerotic disease at high risk for ischemic stroke, despite aggressive medical management. He is also the medical director of the Neurovascular Quality Initiative, board member of the Society of Neurointerventional Surgery, and a co-chair of the FDA’s Coordinated Registry Network – Devices for Acute Ischemic Stroke Intervention.

Hospital Medicine Neurology and Neuroscience Neurosurgery Patient Care Research
Share. Facebook Twitter Email

Related Posts

Celebrating Advances in Alzheimer’s Research and Clinical Care

May 26, 2023

Understanding How Hormones Influence Anemia

May 25, 2023

Groundbreaking Geneticist Delivers Epigenetics Lecture

May 24, 2023

Comments are closed.

Latest News

Celebrating Advances in Alzheimer’s Research and Clinical Care

May 26, 2023

Understanding How Hormones Influence Anemia

May 25, 2023

Groundbreaking Geneticist Delivers Epigenetics Lecture

May 24, 2023

CT Scan Best at Predicting Heart Disease Risk in Middle Age

May 23, 2023

Investigating the Benefits of Salt Substitutes in Elderly Patients

May 22, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230506_NM569
20230506_NM564
20230506_NM563
20230506_NM559
20230506_NM555
20230506_NM549
20230506_NM508
20230506_NM474
20230506_NM136
20230506_NM124
20230506_NM118
20230506_NM094

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.